Gabapentin and weight gain
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin and Weight Gain: Clinical Evidence
Incidence and Magnitude of Weight Gain with Gabapentin
Several studies have found that gabapentin can cause weight gain in a notable proportion of patients. In a long-term study of patients with seizure disorders treated with high-dose gabapentin for at least 12 months, about 57% of patients gained at least 5% of their baseline weight, with 10 patients gaining more than 10% of their initial weight. Weight gain typically began between the second and third months of treatment and tended to stabilize after 6 to 9 months, even if the dose remained unchanged. Only a small number of patients experienced weight loss or no change in weight during therapy . Another review of clinical records found that some patients gained an average of 6.9 kg within a few months of starting gabapentin, especially at higher doses than those used in initial clinical trials .
Comparison with Other Medications
Gabapentin is not the only antiepileptic drug (AED) associated with weight gain. Other AEDs such as pregabalin, valproic acid, and vigabatrin are also linked to weight increases, while some, like lamotrigine and levetiracetam, are considered weight-neutral 78. In a study comparing gabapentin enacarbil (a prodrug of gabapentin) with pregabalin and placebo in patients with diabetic peripheral neuropathy, gabapentin enacarbil was associated with lower rates of weight gain than pregabalin, but higher than placebo. The weight gain with gabapentin enacarbil appeared to be dose-dependent, with up to 10% of patients experiencing a ≥7% weight increase at higher doses 23.
Weight Gain in Different Patient Populations
The risk and extent of weight gain with gabapentin may vary depending on the patient population and the condition being treated. In patients with postherpetic neuralgia, long-term use of a gastroretentive gabapentin formulation resulted in a mean weight gain of less than 1 kg over 24 weeks, with only 2.5% of patients reporting weight increase as an adverse event . In headache prophylaxis, only 9% of patients on gabapentin experienced weight gain of at least 1.5 kg after 6 months, which was lower than the rates seen with other medications like amitriptyline or pizotifen .
Mechanisms and Clinical Considerations
The exact mechanism by which gabapentin causes weight gain is not fully understood, and changes in appetite or eating behavior have not been consistently documented. However, the effect appears to be more pronounced at higher doses and with longer duration of therapy 15. While weight gain is not considered a common side effect in initial clinical trials, real-world use has shown that it can be a significant issue for some patients 58.
Special Cases: Gabapentin and Weight in Neonates
In neonates with neurological impairments and feeding difficulties, gabapentin has been reported to improve feeding tolerance and promote appropriate weight gain, likely due to its effect on reducing pain and irritability rather than a direct metabolic effect .
Conclusion
Gabapentin is associated with weight gain in a significant proportion of patients, especially at higher doses and with long-term use. The risk and extent of weight gain can vary depending on the patient population and the specific formulation used. Compared to some other medications, gabapentin may cause less weight gain, but it is still a relevant clinical consideration, particularly for patients at risk of obesity or related health issues. Regular monitoring of weight and individualized medication selection are important for minimizing this side effect 1234+4 MORE.
Sources and full results
Most relevant research papers on this topic